# PROGRESS.md

## Latest Checkpoint
- **Date:** 2026-10-28
- **Phase:** Phase 0 — Mission alignment (WP-01C)
- **Status:** Mission updated to AI-assisted patient-benefit focus (Discovery + Translation). Dual tracks, patient-benefit framework, AI/hypothesis boundaries added. Preserving T2D scope and WP-02 roadmap. Pending commit/push.

## Completed Work
- [x] Created repository directory structure (`research/`, `research/diseases/type-2-diabetes/`, `templates/`)
- [x] Wrote `AGENTS.md` (safeguards, evidence standards, Git safety)
- [x] Wrote `README.md` (purpose, scope, navigation, status)
- [x] Wrote `PROJECT_PLAN.md` (mission, phases, deliverables, acceptance criteria, risks)
- [x] Wrote `CHANGELOG.md` (initial entry)
- [x] Wrote `.gitignore` (sensitive files, caches, Python/editor)
- [x] Wrote `research/README.md`
- [x] Wrote `research/evidence-methodology.md`
- [x] Initialized `research/source-register.csv` with headers
- [x] Initialized `research/claim-ledger.csv` with headers
- [x] Created disease directory structure for T2D with all required files (placeholder content with governance notes)
- [x] Created templates: `study-appraisal.md`, `candidate-intervention.md`
- [x] Initialized Git on `main`, committed initial plan (6759329)
- [x] Connected to GitHub remote (SSH) and pushed to `origin/main` (WP-01B)
- [x] Aligned mission with AI-assisted patient-benefit focus: Discovery + Translation tracks, patient-benefit framework, AI/hypothesis boundaries, affordability/accessibility (including India), questions for qualified clinicians (WP-01C)

## Outstanding Work
- [ ] Commit and push WP-01C changes with message `docs: clarify AI-assisted patient-benefit mission`
- [ ] Verify commit SHA, upstream tracking, remote state, clean working tree
- [ ] Proceed to WP-02 (Phase 1: Establish T2D remission evidence baseline) as separate commit

## Decisions
- **Documentation-only:** No app implementation; strict medical safeguards enforced.
- **Traceability-first:** Source register + claim ledger required for material claims.
- **Conservative terminology:** Remission distinguished from cure; hypotheses labeled as such.
- **Natural compounds:** Start with listed compounds but require separation of evidence types.
- **Registry verification:** Trial recruiting status must be verified against registry.

## Blockers
- None identified at initialization time.

## Next Recommended Work Package (WP-02)
**Title:** Phase 1 — Establish T2D remission evidence baseline  
**Goal:** Populate `remission-evidence.md`, add DiRECT/DIADEM-I to source-register and claim-ledger with verifiable details.  
**Acceptance Criteria:**
- DiRECT and DIADEM-I entries with design/population/outcomes/follow-up/relapse/limitations
- Remission definition documented with study criteria noted
- All material claims traced or explicitly flagged unverified
- Sources verified against primary sources where introduced as factual findings
**Priority:** High
